NeoGenomics, Inc. Common Stock NEO
HEALTHCARE · DIAGNOSTICS & RESEARCHi
Market dataready · fetched 2026-11-12T02:41:27.149Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:31:53.193860315Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T02:41:26.588032+00:00
NeoGenomics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 13.43 | 223.3% | 25.2% | |||
| 25Δ | ||||||
| 30Δ | 18.31 | 88.0% | 11.1% | 15.32 | 152.3% | 14.4% |
| 35Δ | 18.08 | 94.5% | 10.4% | 15.94 | 131.3% | 11.1% |
| 40Δ | 17.77 | 91.9% | 9.0% | 16.36 | 119.5% | 9.1% |
| 45Δ | 17.40 | 83.9% | 7.1% | 16.75 | 108.6% | 7.2% |
| 50Δ | 17.04 | 75.8% | 5.3% | 17.08 | 99.0% | 5.7% |
| 55Δ | 16.71 | 84.8% | 4.9% | 17.31 | 91.5% | 4.7% |
| 60Δ | 16.38 | 95.7% | 4.6% | 17.54 | 84.1% | 3.8% |
| 65Δ | 16.06 | 106.5% | 4.4% | 17.77 | 76.6% | 2.8% |
| 70Δ | 15.67 | 108.9% | 3.7% | 18.01 | 69.4% | 1.9% |
| 75Δ | 15.26 | 109.4% | 2.9% | 18.58 | 74.5% | 1.5% |
| 80Δ | 14.83 | 109.4% | 2.2% | 19.14 | 79.7% | 1.2% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 13.43
- IV
- 223.3%
- B/E move
- 25.2%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- 18.31
- IV
- 88.0%
- B/E move
- 11.1%
- Pseudo strike
- 15.32
- IV
- 152.3%
- B/E move
- 14.4%
35Δ
- Pseudo strike
- 18.08
- IV
- 94.5%
- B/E move
- 10.4%
- Pseudo strike
- 15.94
- IV
- 131.3%
- B/E move
- 11.1%
40Δ
- Pseudo strike
- 17.77
- IV
- 91.9%
- B/E move
- 9.0%
- Pseudo strike
- 16.36
- IV
- 119.5%
- B/E move
- 9.1%
45Δ
- Pseudo strike
- 17.40
- IV
- 83.9%
- B/E move
- 7.1%
- Pseudo strike
- 16.75
- IV
- 108.6%
- B/E move
- 7.2%
50Δ
- Pseudo strike
- 17.04
- IV
- 75.8%
- B/E move
- 5.3%
- Pseudo strike
- 17.08
- IV
- 99.0%
- B/E move
- 5.7%
55Δ
- Pseudo strike
- 16.71
- IV
- 84.8%
- B/E move
- 4.9%
- Pseudo strike
- 17.31
- IV
- 91.5%
- B/E move
- 4.7%
60Δ
- Pseudo strike
- 16.38
- IV
- 95.7%
- B/E move
- 4.6%
- Pseudo strike
- 17.54
- IV
- 84.1%
- B/E move
- 3.8%
65Δ
- Pseudo strike
- 16.06
- IV
- 106.5%
- B/E move
- 4.4%
- Pseudo strike
- 17.77
- IV
- 76.6%
- B/E move
- 2.8%
70Δ
- Pseudo strike
- 15.67
- IV
- 108.9%
- B/E move
- 3.7%
- Pseudo strike
- 18.01
- IV
- 69.4%
- B/E move
- 1.9%
75Δ
- Pseudo strike
- 15.26
- IV
- 109.4%
- B/E move
- 2.9%
- Pseudo strike
- 18.58
- IV
- 74.5%
- B/E move
- 1.5%
80Δ
- Pseudo strike
- 14.83
- IV
- 109.4%
- B/E move
- 2.2%
- Pseudo strike
- 19.14
- IV
- 79.7%
- B/E move
- 1.2%
Options history
Table
| Date | IV (%) |
|---|---|
| 61.58% | |
| 65.36% | |
| 67.16% | |
| 69.44% | |
| 61.68% | |
| 60.70% | |
| 65.62% | |
| 64.96% | |
| 64.33% | |
| 57.69% |
Diagnostics & Research
NTRA
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
More →OPK
OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and…
More →PSNL
Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
More →QGEN
QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.
More →RDNT
RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California.
More →RVTY
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. The company is headquartered in Waltham,…
More →